Diagnostics

Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million Patients

The milestone underscores Arkstone's leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding…

1 month ago

Pictor Labs Expands AI Pathology Portfolio with Launch of ClearStain™ for Digital Sequencing Workflows

New virtual staining solution enhances molecular diagnostics performance, preserves tissue, and accelerates turnaround times NATIONAL HARBOR, Md., Nov. 6, 2025…

1 month ago

Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential

Certification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire…

1 month ago

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica’s updated website…

1 month ago

Veterinary Referral Center of Central Oregon Launches PetsForward

A New Nonprofit Expanding Access to Advanced Veterinary Care BEND, OR / ACCESS Newswire / November 5, 2025 / What…

1 month ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

SALT LAKE CITY, Nov. 5, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…

1 month ago

From Whitening to AI Diagnostics: Robert Hayman, the Visionary Behind Zoom! Whitening, Leads Dentistry’s Next Global Breakthrough

REDMOND, Wash., Nov. 5, 2025 /PRNewswire/ -- Following the first FDA clearance for technology that measures internal mobility in teeth,…

1 month ago

NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance

Landmark collaboration with Caristo Diagnostics positions NCH at the forefront of preventive cardiology NCH cardiologists to present collaboration plans at American…

1 month ago

YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring

Taipei, Taiwan, Nov. 05, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology…

1 month ago

CelLBxHealth PLC Presents Proof-of-Concept Study

CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics' workflow at world-leading drug development conferenceParsortix platform shown to be compatible with…

1 month ago